This is an opportunity to learn about the medications you have been prescribed and ask important questions like the following ...

CMS has finalized several changes for the third round of Medicare drug price negotiations. The changes, outlined in a final guidance issued Sept. 30, include expanded exclusions for orphan drugs and a ...

Panelists discuss how the subcutaneous nivolumab data demonstrate reassuring safety with minimal grade 3/4 events, how ...